Yıl: 2022 Cilt: 54 Sayı: 2 Sayfa Aralığı: 186 - 190 Metin Dili: İngilizce DOI: 10.5152/eurasianjmed.2022.21293 İndeks Tarihi: 05-07-2022

High Fetuin-A Levels in Children with Celiac Disease

Öz:
Objective: Fetuin-A is a multifunctional non-collagen protein that plays a role in bone mineralization. Celiac disease is a chronic inflammatory disorder of the small intestine due to exposure to gluten. In this research, it was aimed to investigate levels of Fetuin-A and its relationship with bone mineral density in children with celiac disease. Materials and Methods: The study was conducted on 59 children with celiac and 29 healthy children. The celiac disease group was composed of three groups, newly diagnosed, gluten-free diet compliant and, non- glutenfree diet compliant patients. Serum Fetuin-A concentrations were measured by an enzyme-linked immunosorbent assay kit. Measurement of bone mineral density was performed a dual-energy x-ray absorptiometry. Results: Serum Fetuin-A levels were 136.85 ± 38.09 μg/L and 112.95 ± 44.39 μg/L in the celiac disease and healthy control groups, respectively. There was a statistically significant difference between groups in levels of serum Fetuin-A (P < .05). A significant positive correlation was observed between serum Fetuin-A and bone mineral density Z-score in the celiac patients. Conclusion: Increased Fetuin-A levels and positive correlation between Fetuin-A and bone mineral density in children with celiac disease suggest that Fetuin-A may be a biomarker for celiac disease.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Tack GJ, Verbeek WH, Schreurs MW, Mulder CJ. The spectrum of celiac disease: epidemiology, clinical aspects and treatment. Nat Rev Gastroenterol Hepatol. 2010;7(4):204-213. [CrossRef]
  • 2. Newton KP, Singer SA. Celiac disease in children and adolescents: special considerations. Semin Immunopathol. 2012;34(4):479-496. [CrossRef]
  • 3. Phan CM, Guglielmi G. Metabolic bone disease in patients with malabsorption. Semin Musculoskelet Radiol. 2016;20(4):369-375. [CrossRef]
  • 4. Kemppainen T, Kröger H, Janatuinen E, et al.. Osteoporosis in adult patients with celiac disease. Bone. 1999;24(3):249-255. [CrossRef]
  • 5. Sdepanian VL, de Miranda Carvalho CN, de Morais MB, Colugnati FA, Fagundes-Neto U. Bone mineral density of the lumbar spine in children and adolescents with celiac disease on gluten-free diet in Sao Paulo, Brasil. J Pediatr Gastroenterol Nutr. 2003;37(5):571-576. [CrossRef]
  • 6. Volkan B, Fettah A, İşlek A, Kara SS, Kurt N, Çayır A. Bone mineral density and vitamin K status in children with celiac disease: is there a relation? Turk J Gastroenterol. 2018;29(2):215-220. [CrossRef]
  • 7. Mori K, Emoto M, Inaba M. Fetuin-A: a multifunctional protein. Recent Pat Endocr Metab Immune Drug Discov. 2011;5(2):124-146. [CrossRef]
  • 8. Termine JD, Belcourt AB, Conn KM, Kleinman HK. Mineral and collagen-binding proteins of fetal calf bone. J Biol Chem. 1981;256(20):10403- 10408. [CrossRef]
  • 9. Wendel M, Heinegård D, Franzén A. A major non-collagenous 62 kDa protein from rat bone mineralized matrix is identical to pp63 a phosphorylated glycoprotein from liver. Matrix. 1993;13(4):331-339. [CrossRef]
  • 10. Schafer C, Heiss A, Schwarz A, et al. The serum protein alpha 2-Heremans-Schmid glycoprotein/ fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest. 2003;112(3):357- 366. [CrossRef]
  • 11. Westenfeld R, Schäfer C, Smeets R, et al. Fetuin- A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in mice. Nephrol Dial Transplant. 2007;22(6):1537- 1546. [CrossRef]
  • 12. Westenfeld R, Schäfer C, Krüger T, et al. Fetuin- A protects against atherosclerotic calcification in CKD. J Am Soc Nephrol. 2009;20(6):1264-1274. [CrossRef]
  • 13. Schinke T, Amendt C, Trindl A, Pöschke O, Müller-Esterl W, Jahnen-Dechent W. The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis. J Biol Chem. 1996;271(34):20789-20796. [CrossRef]
  • 14. Price PA, Toroian D, Lim JE. Mineralization by inhibitor exclusion: the calcification of collagen with fetuin. J Biol Chem. 2009;284(25):17092- 17101. [CrossRef]
  • 15. Toroian D, Lim JE, Price PA. The size exclusion characteristics of type I collagen: implications for the role of noncollagenous bone constituents in mineralization. J Biol Chem. 2007;282(31):22437- 22447. [CrossRef]
  • 16. Ix JH, Wassel CL, Bauer DC, et al. Fetuin-A and BMD in older persons: the Health Aging and Body Composition (Health ABC) study. J Bone Miner Res. 2009;24(3):514-521. [CrossRef]
  • 17. Chailurkit L, Kruavit A, Rajatanavin R, Ongphiphadhanakul B. The relationship of fetuin-A and lactoferrin with bone mass in elderly women. Osteoporos Int. 2011;22(7):2159-2164. [CrossRef]
  • 18. Husby S, Koletzko S, Korponay-Szabó IR, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54(1):136-160. [CrossRef]
  • 19. Neyzi O, Gunoz H, Furman A, Bundak R, Gokcay G, Weight DF. height, head circumference and body mass index references for Turkish children. J Pediatr. 2008;51:1-14.
  • 20. Lewiecki EM, Gordon CM, Baim S, et al. International Society for Clinical densitometry 2007 adult and pediatric official positions. Bone. 2008;43(6):1115-1121. [CrossRef]
  • 21. Kalayci AG, Kansu A, Girgin N, Kucuk O, Aras G. Bone mineral density and importance of a glutenfree diet in patients with celiac disease in childhood. Pediatrics. 2001;108(5):E89. [CrossRef]
  • 22. Blazina S, Bratanic N, Campa AS, Blagus R, Orel R. Bone mineral density and importance of strict gluten-free diet in children and adolescents with celiac disease. Bone. 2010;47(3):598-603. [CrossRef]
  • 23. Binkert C, Demetriou M, Sukhu B, Szweras M, Tenenbaum HC, Dennis JW. Regulation of osteogenesis by fetuin. J Biol Chem. 1999;274(40):28514-28520. [CrossRef]
  • 24. Heiss A, DuChesne A, Denecke B, et al. Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles. J Biol Chem. 2003;278(15):13333-13341. [CrossRef]
  • 25. Herrmann M, Schäfer C, Heiss A, et al. Clearance of fetuin-A--containing calciprotein particles is mediated by scavenger receptor-A. Circ Res. 2012;111(5):575-584. [CrossRef]
  • 26. Toroian D, Price PA. The essential role of fetuin in the serum-induced calcification of collagen. Calcif Tissue Int. 2008;82(2):116-126. [CrossRef]
  • 27. Rasul S, Ilhan A, Reiter MH, et al. Levels of fetuin- A relate to the levels of bone turnover biomarkers in male and female [patients with type 2 diabetes. Clin Endocrinol (Oxf ). 2012;76(4):499-505. [CrossRef]
  • 28. Ambroszkiewicz J, Rowicka G, Chelchowska M, Gajewska J, Strucińska M, Laskowska-Klita T. Biochemical markers of bone metabolism in children with cow’s milk allergy. Arch Med Sci. 2014;10(6):1135-1141. [CrossRef]
  • 29. Özkan E, Özkan H, Bilgiç S, et al. Serum fetuin-A levels in postmenopausal women with osteoporosis. Turk J Med Sci. 2014;44(6):985-988. [CrossRef]
APA KURT N, OZGERIS F, Volkan B, Gül M, Cayir A (2022). High Fetuin-A Levels in Children with Celiac Disease. , 186 - 190. 10.5152/eurasianjmed.2022.21293
Chicago KURT Nezahat,OZGERIS FATMA BETÜL,Volkan Burcu,Gül Mehmet Ali,Cayir Atilla High Fetuin-A Levels in Children with Celiac Disease. (2022): 186 - 190. 10.5152/eurasianjmed.2022.21293
MLA KURT Nezahat,OZGERIS FATMA BETÜL,Volkan Burcu,Gül Mehmet Ali,Cayir Atilla High Fetuin-A Levels in Children with Celiac Disease. , 2022, ss.186 - 190. 10.5152/eurasianjmed.2022.21293
AMA KURT N,OZGERIS F,Volkan B,Gül M,Cayir A High Fetuin-A Levels in Children with Celiac Disease. . 2022; 186 - 190. 10.5152/eurasianjmed.2022.21293
Vancouver KURT N,OZGERIS F,Volkan B,Gül M,Cayir A High Fetuin-A Levels in Children with Celiac Disease. . 2022; 186 - 190. 10.5152/eurasianjmed.2022.21293
IEEE KURT N,OZGERIS F,Volkan B,Gül M,Cayir A "High Fetuin-A Levels in Children with Celiac Disease." , ss.186 - 190, 2022. 10.5152/eurasianjmed.2022.21293
ISNAD KURT, Nezahat vd. "High Fetuin-A Levels in Children with Celiac Disease". (2022), 186-190. https://doi.org/10.5152/eurasianjmed.2022.21293
APA KURT N, OZGERIS F, Volkan B, Gül M, Cayir A (2022). High Fetuin-A Levels in Children with Celiac Disease. Eurasian Journal of Medicine, 54(2), 186 - 190. 10.5152/eurasianjmed.2022.21293
Chicago KURT Nezahat,OZGERIS FATMA BETÜL,Volkan Burcu,Gül Mehmet Ali,Cayir Atilla High Fetuin-A Levels in Children with Celiac Disease. Eurasian Journal of Medicine 54, no.2 (2022): 186 - 190. 10.5152/eurasianjmed.2022.21293
MLA KURT Nezahat,OZGERIS FATMA BETÜL,Volkan Burcu,Gül Mehmet Ali,Cayir Atilla High Fetuin-A Levels in Children with Celiac Disease. Eurasian Journal of Medicine, vol.54, no.2, 2022, ss.186 - 190. 10.5152/eurasianjmed.2022.21293
AMA KURT N,OZGERIS F,Volkan B,Gül M,Cayir A High Fetuin-A Levels in Children with Celiac Disease. Eurasian Journal of Medicine. 2022; 54(2): 186 - 190. 10.5152/eurasianjmed.2022.21293
Vancouver KURT N,OZGERIS F,Volkan B,Gül M,Cayir A High Fetuin-A Levels in Children with Celiac Disease. Eurasian Journal of Medicine. 2022; 54(2): 186 - 190. 10.5152/eurasianjmed.2022.21293
IEEE KURT N,OZGERIS F,Volkan B,Gül M,Cayir A "High Fetuin-A Levels in Children with Celiac Disease." Eurasian Journal of Medicine, 54, ss.186 - 190, 2022. 10.5152/eurasianjmed.2022.21293
ISNAD KURT, Nezahat vd. "High Fetuin-A Levels in Children with Celiac Disease". Eurasian Journal of Medicine 54/2 (2022), 186-190. https://doi.org/10.5152/eurasianjmed.2022.21293